January 16, 2014
Timo Minssen (Petrie-Flom Visiting Scholar) and Jens Schovsbo


Read the Full Article

Abstract: This perspective-article provides an overview on selected legal aspects of biobanking. It discusses these issues with a focus on public biobanks in a university setting and the specific challenges posed by personalized medicine (PM). We conclude that any decisions as to the design of the regulatory environment should follow a process that takes account of the values, hopes and concerns of all stakeholders involved. In particular, we stress the importance of a careful planning of consent obligations combining traditional legal methods with an adequate institutional set up. In order to enhance the translational exploitation of biobanks, we further emphasize the pressing need to carefully consider a great variety of strategies and policy choices relating to intellectual property rights (IPRs). 

NB: This paper is currently undergoing peer-review for publication in the medical journal "Personlized Medicine" published by Future Medicine Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK (registered in England & Wales, No: 4059017); VAT No: GB 833 0029 67.

bioethics biotechnology genetics health law policy human tissue innovation intellectual property regulation